What do you do when your PK/PD study demands impeccable timing, zero deviation, and novel biomarker development? For this double-dummy, placebo-controlled Phase 1 trial assessing two CNS-targeted drug formulations, a sponsor needed a partner who could manage over 4,620 tightly scheduled PK and PD sample times without missing a single one. They turned to Clinilabs.
Get an inside look at how Clinilabs supported a high-complexity Phase 1I trial by:
- Initiating the trial in just 10 weeks
- Executing a 3:1 staff-to-subject ratio for precise sampling and safety
- Seamlessly coordinating QEEG, psychometric, and neuroendocrine assessments
- Delivering validated biomarkers to support further CNS drug development
Ready to see what precision CNS trial execution really looks like?
